JENNA RHOTON: Open Payments
NPI 1134769375 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,719 in 113 payments from 23 companies in 2025. Trend: 2023 $7,736 · 2024 $8,069 · 2025 $4,719
Speaker / faculty: $3,000Food & beverage: $1,714Travel & lodging: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $3,583 |
| Novartis Pharmaceuticals Corporation | 10 | $230 |
| Biogen, Inc. | 8 | $153 |
| PFIZER INC. | 17 | $140 |
| SK Life Science, Inc. | 3 | $62 |
| Lundbeck LLC | 3 | $60 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
| Cala Health, Inc. | 2 | $48 |
| Celgene Corporation | 2 | $44 |
| Eisai Inc. | 2 | $43 |
Products named: QULIPTA, UBRELVY, KESIMPTA, TYSABRI, NURTEC ODT, BOTOX, VYEPTI, Cala kIQ.
Industry payments across UT — which companies pay providers there.
